✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹2,214 Cr.
P/E
40.60

Key Ratios

Market cap
Market cap
2,214 Cr
PE
PE
40.60
Prom Holding
Prom Holding
46.52 %
ROE (%)
ROE (%)
15.56
ROCE (%)
ROCE (%)
20.82
Div Yield (%)
Div Yield (%)
0.60
Sales
Sales
462 Cr
OPM (%)
OPM (%)
13.65 %
Debt to Equity
Debt to Equity
-
About
Amrutanjan Health Care Ltd specializes in the manufacturing of a diverse range of ayurvedic an… Read more
Low
544
52W Range
High
843
  • Amrutanjan Healthcar
  • Max India
  • Sastasundar Ventures
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
0.04 %
(as of Nov 21)
Dermatology - Market Share
43.10 %
(as of Mar 21)
Head Balm - Market Share
2 %
(as of Mar 20)
Sanitary Napkins - Market Share
Revenue mix

Product Wise Break-Up

Product Wise Break-Up - OTC Products

Location Wise Break-Up

Operating Profit Break-Up

Brand Wise Break-Up

Asset Break-Up

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Amrutanjan Decorn corn caps
    Amrutanjan Fruitnik
    Amrutanjan Relief Cold Rub
    Comfy Snug Fit
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Amrutanjan Health Care Ltd. Business

    Amrutanjan Health Care Ltd manufactures a variety of ayurvedic and allopathic products available in several countries worldwide. The company also plans to expand into the US and European markets with a diverse product portfolio including pain relief products, ointments, and supplements.

    Amrutanjan Healthcar major competitors are Max India, Sastasundar Ventures, Rajnish Wellness, Cupid, Medplus Health Servi, Jeena Sikho Life, Dr Agarwals Eye Hsp.
    Market Cap of Amrutanjan Healthcar is ₹2,214 Crs.
    While the median market cap of its peers are ₹2,221 Crs.

    Amrutanjan Healthcar seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material